Open AccessA PROSPECTIVE RANDOMIZED TRIAL OF ALEMTUZUMAB VERSUS RABBIT ANTI-THYMOCYTE GLOBULIN INDUCTION IN KIDNEY AND PANCREAS TRANSPLANTATION: MINIMUM 6 MONTHS FOLLOW-UP
Author(s) -
Alan C. Farney,
Rajinder Singh,
Jeffrey Rogers,
Eshan Ashcroft,
Erika Hartmann,
Lawrence E. Hart,
William Doares,
Michael D. Gautreaux,
Patricia L. Adams,
Robert J. Stratta
Publication year - 2008
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000332021.15529.f1
Subject(s) - alemtuzumab , anti thymocyte globulin , medicine , globulin , transplantation , pancreas transplantation , induction therapy , kidney transplantation , urology , chemotherapy